QGEN Qiagen NV

  1. Stocks
  2. Healthcare
  3. NYSE: QGEN

Price (delayed)

$50.105

Market cap

$10.35B

P/E Ratio

27.23

Dividend/share

$2.64

EPS

$1.84

Enterprise value

$11.18B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 70

QIAGEN N.V., (QIAGEN) is a holding company, which provides sample and assay technologies. The consumable products such as sample and assay kits and automated instrumentation systems provides customers to transform ...

Highlights
The debt has declined by 23% year-on-year
The company's revenue rose by 2.2% YoY
The price to earnings (P/E) is 37% lower than the 5-year quarterly average of 43.6 but 24% higher than the last 4 quarters average of 22.1
QGEN's equity is down by 4.8% YoY but it is up by 3.5% QoQ
Qiagen's quick ratio has decreased by 12% YoY and by 9% QoQ
The company's net income fell by 6% QoQ and by 5% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.qiagen.com
Peers: TMO BDX GE TECH

Key stats

What are the main financial stats of QGEN

QGEN stock price

How has the Qiagen stock price performed over time
Intraday
-0.39%
1 week
-1.48%
1 month
10.58%
1 year
12.52%
YTD
11.42%
QTD
14.5%

Financial performance

How have Qiagen's revenue and profit performed over time
Revenue
$2.12B
Gross profit
$1.33B
Operating income
$448.74M
Net income
$384.93M
Gross margin
62.8%
Net margin
18.2%
The operating margin has declined by 9% year-on-year
Qiagen's operating income has decreased by 8% YoY
The net margin has declined by 7% year-on-year and by 7% since the previous quarter
The company's net income fell by 6% QoQ and by 5% YoY

Price vs fundamentals

How does QGEN's price correlate with its fundamentals

Growth

What is Qiagen's growth rate over time

Valuation

What is Qiagen stock price valuation
QGEN P/E details
P/E
27.23
P/B
2.98
P/S
4.89
EV/EBIT
22.32
EV/EBITDA
15.86
EV/Sales
5.29
The price to earnings (P/E) is 37% lower than the 5-year quarterly average of 43.6 but 24% higher than the last 4 quarters average of 22.1
Qiagen's EPS has decreased by 4.7% from the previous quarter
The stock's price to book (P/B) is 15% more than its last 4 quarters average of 2.6 and 3.1% more than its 5-year quarterly average of 2.9
QGEN's equity is down by 4.8% YoY but it is up by 3.5% QoQ
QGEN's price to sales (P/S) is 17% higher than its last 4 quarters average of 4.2 and 2.3% higher than its 5-year quarterly average of 4.8
The company's revenue rose by 2.2% YoY

Efficiency

How efficient is Qiagen business performance
The company's return on invested capital fell by 16% YoY but it rose by 2.7% QoQ
Qiagen's ROS has decreased by 9% YoY
QGEN's return on assets is down by 7% year-on-year and by 4.5% since the previous quarter
QGEN's ROE is down by 5% from the previous quarter and by 4.3% YoY

Dividends

What is QGEN's dividend history
Dividend details
DPS
$2.64
Dividend yield
5.27%
Payout ratio
143.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Qiagen financials performed over time
Qiagen's total assets is 141% higher than its total liabilities
The total liabilities has declined by 15% year-on-year and by 2.5% since the previous quarter
Qiagen's quick ratio has decreased by 12% YoY and by 9% QoQ
The debt is 53% smaller than the equity
The debt has declined by 23% year-on-year
Qiagen's debt to equity has decreased by 19% YoY and by 4.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.